Mabxience Research S.l.

This study is testing whether a proposed biosimilar drug called MB12 works as well as the established drug Keytruda (pembrolizumab) for treating advanced non-squamous non-small cell lung cancer. Both drugs are given in combination with standard chemotherapy. The main goals are to…

This study is testing if a new drug called MB11 works the same as the established cancer drug Opdivo (nivolumab) for people with advanced melanoma that cannot be removed by surgery or has spread. It's a large, late-stage trial involving 632 adults who have not yet received treatm…